Long-Term Results and Competing Risk Analysis of the H89 Trial in Patients With Advanced-Stage Hodgkin Lymphoma: A Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)

Blood - United States
doi 10.1182/blood-2005-11-4429

Related search